Immunological Monitoring in a Controlled Trial of Immunotherapy in Stage IIB Malignant Melanoma

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1978.77
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC